Knee gel injections, known clinically as viscosupplementation, are shots of hyaluronic acid into an arthritic knee. The reason quotes vary so wildly is not the gel. It is arithmetic: some brands are one shot, some are three, some are five, and every extra shot is another office visit with its own injection fee.
The second reason is that a cash payer buys the drug on a completely different market from everyone else. Medicare and commercial plans pay a published, regulated drug allowance. A self-pay patient buying the same syringe at a retail pharmacy pays several times that. This guide separates the drug cost, the injection fee, and the imaging guidance fee so you can see exactly which line is inflating your quote. All figures are current as of August 2026.
What Do Knee Gel Injections Cost Without Insurance?
The drug prices below are the Medicare Part B payment allowances from the July 2026 CMS ASP pricing file, multiplied by the FDA-approved dose and shot count for each brand. They are what a payer pays for the gel, and they are the number to anchor your negotiation on.
| Brand, course, or fee | Low | Average | High |
|---|---|---|---|
| TriVisc (3 shots), gel only at 2026 Medicare rates | n/a | $228 | n/a |
| Synvisc-One (1 shot), gel only | n/a | $289 | n/a |
| Synvisc (3 shots), gel only | n/a | $289 | n/a |
| Euflexxa (3 shots), gel only | n/a | $294 | n/a |
| GelSyn-3 (3 shots), gel only | n/a | $294 | n/a |
| Orthovisc (3 to 4 shots), gel only | $301 | n/a | $401 |
| Supartz FX or Hyalgan (5 shots), gel only | n/a | $351 | n/a |
| Durolane (1 shot), gel only | n/a | $374 | n/a |
| GenVisc 850 (5 shots), gel only | n/a | $476 | n/a |
| Gel-One (1 shot), gel only | n/a | $534 | n/a |
| Monovisc (1 shot), gel only | n/a | $565 | n/a |
| Hymovis (2 shots), gel only | n/a | $870 | n/a |
| Synvisc 3-syringe course at retail pharmacy cash price | $1,346 | n/a | $2,006 |
| GenVisc 850 or TriVisc through a direct-pay program, per syringe | n/a | $97 | n/a |
| Injection visit in an office, cash price | $134 | $192 | $636 |
| Injection at a surgery center, Medicare 2026 total (CPT 20610) | n/a | $77 | n/a |
| Injection at a hospital outpatient department, Medicare 2026 | n/a | $352 | n/a |
| Same injection with ultrasound guidance (CPT 20611), ASC to hospital | $114 | n/a | $363 |
| All-in cash, single-injection product | $425 | n/a | $1,200 |
| All-in cash, three-injection course | $630 | n/a | $2,200 |
| All-in cash, five-injection course | $1,020 | n/a | $3,650 |
The per-brand gel figures combine two sources. The dose and shot count come from Aetna’s clinical policy bulletin on viscosupplementation, which reproduces the FDA-approved dosing for every product on the market: Synvisc is 16 mg weekly for three weeks, Synvisc-One is a single 48 mg injection, Euflexxa is 20 mg weekly for three, Orthovisc is 30 mg weekly for three to four, Supartz FX and Hyalgan are weekly for five, and Gel-One, Monovisc and Durolane are one-and-done. The dollar figures come from the July 2026 CMS ASP file, which prices Synvisc at $6.018 per mg, Durolane at $6.239 per mg, Euflexxa at $98.137 per dose, Gel-One at $533.592 per dose and Monovisc at $565.275 per dose.
Notice how flat that column is. Nine of the twelve brands land between $228 and $534 for a complete course of gel. If your quote for the medication alone is well over $600, you are being charged a retail markup, not a difference in product.
What Drives the Price
How many shots your brand requires
This is the single biggest lever and the one patients almost never ask about. A five-shot course of GenVisc 850 costs about $476 in gel and requires five separate visits. A single Durolane injection costs about $374 in gel and requires one. At the $134 to $636 per-visit cash range MDsave publishes for an in-office joint injection, four extra visits can add $536 to $2,544 to an otherwise similar treatment.
Where the needle goes in
The identical shot is priced three different ways depending on the building. Medicare’s 2026 Procedure Price Lookup puts CPT 20610, a major joint injection without imaging guidance, at $77 total in an ambulatory surgery center and $352 total in a hospital outpatient department. The physician’s share is $39 in both places. The entire $275 gap is the hospital facility fee. Cash payers face the same structure, usually magnified.
Ultrasound or fluoroscopic guidance
Guidance is billed separately as CPT 20611. Medicare’s 2026 figures put it at $114 total in a surgery center against $77 without guidance, so the imaging itself adds about $37. In a hospital outpatient department the difference nearly disappears, because the facility fee is $313 either way and only the doctor’s fee rises from $39 to $50. Guidance is not always necessary for a knee, which is one of the easiest joints to inject blind, so ask whether it is being added by protocol or by need.
Retail versus payer pricing on the gel
A cash payer sent to a pharmacy with a prescription pays retail. SingleCare lists the average retail price of one 16 mg Synvisc syringe at $668.69, discounted to $448.50 with its coupon. That is $2,006 retail or $1,346 discounted for the three syringes a full Synvisc course requires, against roughly $289 at the Medicare allowance for the exact same medication. Nothing about the product changed. Only the buyer did.
Whether the practice buys and bills
Most orthopedic offices buy the gel themselves and bill it to you as part of the visit, which is usually cheaper than a pharmacy route. Some route you to a specialty pharmacy instead. Ask which model your provider uses, because it changes your total by four figures.
Cash Price vs. Insurance
Knee gel injections are one of the rare treatments where insured patients genuinely get a better deal, and it is worth knowing why before you walk away from coverage.
Medicare covers hyaluronan knee injections, but narrowly. The local coverage determination on intraarticular knee injections of hyaluronan limits coverage to osteoarthritis of the knee, requires that you have failed at least three months of conservative therapy, requires that at least six months have elapsed since a prior series, and explicitly excludes joints other than the knee, use as the initial treatment of knee osteoarthritis, and use after knee replacement. Commercial plans layer prior authorization on top. Aetna’s policy states that precertification is required of all participating providers and members in applicable plan designs, and sets six criteria including an inadequate response to intra-articular steroid injections for at least three months.
That paperwork is the reason many people give up and pay cash. It is usually the wrong trade. If you meet the criteria, the covered path costs you a coinsurance share of a regulated allowance, and Medicare patients pay $14 of the $77 surgery center total. The cash path costs you the entire retail price of both the drug and the visit.
If you are genuinely uninsured, the flip side applies: nobody is going to prior-authorize anything, so you can be treated the week you decide to be. Use the fair price checker to sanity-check a quote before you agree to a course.
How to Pay Less
Ask for the drug price and the injection price separately. This is the single most useful question. A practice quoting “$1,400 for gel injections” is bundling a gel that costs it a few hundred dollars with visits that cost a few hundred more. Once the two lines are separated you can push on each. Our guide to reading an itemized bill covers how to force that breakdown after the fact if you were not given one up front.
Choose the brand by total shots, not by name. If a practice offers more than one product, the honest comparison is gel cost plus injection fees times the number of visits. A single-shot Durolane or Synvisc-One course at $374 or $289 in gel plus one $134 to $636 visit almost always beats a five-shot Supartz course at $351 in gel plus five visits.
Buy the gel through a manufacturer direct-pay program. OrthogenRx and Fidia run Rx-Direct, which prices GenVisc 850 and TriVisc syringes at $97 each regardless of whether you need a three-shot or five-shot series, which is $291 or $485 for a full course. The program notes that the same injections can otherwise cost up to $1,300 for a three-shot series and that the spend is HSA and FSA eligible. Ask whether your practice will administer a gel you supply this way.
Get it in an office or surgery center, never a hospital outpatient clinic. The Medicare data makes the case: $77 versus $352 for the identical CPT code. If your orthopedist’s group owns a hospital-based clinic and a freestanding office, book the office. If you have already been billed at hospital rates, the hospital price transparency guide explains how to pull the facility’s own posted cash rate and hold it to that.
Shop the injection visit itself. MDsave’s national range for an in-office joint injection with ultrasound guidance is $134 to $636 with a national average of $192, which is a four-and-a-half-fold spread for the same fifteen minutes. Bundled cash prices are prepaid and non-negotiable once purchased, which is exactly why they are often lower than what a practice quotes over the phone.
Negotiate the quote before the first shot, not after the fifth. A course of five injections is five separate charges, and a practice that will not move on one visit will often move on a package. Our negotiation script has the language, and the how to negotiate medical bills guide covers what to do if you have already run up a balance.
Check charity care if the practice is hospital-owned. Orthopedic groups owned by nonprofit health systems are usually covered by that system’s financial assistance policy, and viscosupplementation for arthritis is medically necessary care, not cosmetic. Run the charity care check and read the hospital charity care guide before you assume you have to pay list price.
How This Compares to the Alternatives
Gel injections sit in the middle of a ladder. Below them, a cortisone shot is dramatically cheaper because the steroid itself costs a few dollars, so you are paying almost entirely for the injection visit. Above them, PRP injections cost more per shot and are essentially never covered by insurance, which makes the cash comparison closer than it looks on paper.
Further up the ladder are the surgeries. A course of gel injections is a fraction of a knee replacement, a meniscus repair, or a hip replacement. Both Medicare’s coverage rules and Aetna’s policy assume the same sequencing: conservative care first, then steroid injections, then gel, with joint replacement as the endpoint. Physical therapy is the conservative step most cash payers skip, and skipping it is also what disqualifies people from coverage later.
The Bottom Line
Expect $425 to $1,200 for a single-injection product and $630 to $2,200 for a three-shot course as a cash payer in 2026, with five-shot courses reaching $3,650. The gel is the small half of that: nine of the twelve brands on the market cost between $228 and $534 for a complete course at 2026 Medicare drug pricing.
If a quote lands above these ranges, the cause is almost always retail pharmacy pricing on the drug or a hospital outpatient facility fee on the visit. Both are fixable, and fixing either is worth more than switching brands.